These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2442539)

  • 21. Cardiopulmonary regulation after rapid-eye-movement sleep deprivation.
    DeMesquita S; Hale GA
    J Appl Physiol (1985); 1992 Mar; 72(3):970-6. PubMed ID: 1568993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central actions of agmatine in conscious spontaneously hypertensive rats.
    Briaud S; Zhang BL; Sannajust F
    Clin Exp Hypertens; 2005 Nov; 27(8):619-27. PubMed ID: 16303638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of clonidine-like drugs in pithed rabbits.
    Pompermayer K; Salgado MC; Feldman J; Bousquet P
    Hypertension; 1999 Oct; 34(4 Pt 2):1012-5. PubMed ID: 10523400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the involvement of alpha-2 adrenoceptors in the sedation but not REM sleep inhibition by clonidine in the rat.
    Mäkelä JP; Hilakivi IT
    Med Biol; 1986; 64(6):355-60. PubMed ID: 3029520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
    Sy GY; Bruban V; Bousquet P; Feldman J
    Hypertension; 2001 Feb; 37(2):246-9. PubMed ID: 11230279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.
    Gomez RE; Ernsberger P; Feinland G; Reis DJ
    Eur J Pharmacol; 1991 Mar; 195(2):181-91. PubMed ID: 1651861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular variability after clonidine challenge: assessment of dose-dependent temporal effects by means of spectral analysis.
    Tulen JH; Smeets FM; Man in 't Veld AJ; van Steenis HG; van de Wetering BJ; Moleman P
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):112-9. PubMed ID: 7690082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular responses to central clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats following naloxone.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1985; 7(2):321-6. PubMed ID: 2581087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats.
    Koenig-Berard E; Tierney C; Beau B; Delbarre G; Lhoste F; Labrid C
    Am J Cardiol; 1988 Feb; 61(7):22D-31D. PubMed ID: 2894153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats.
    Kawasaki H; Takasaki K
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):217-33. PubMed ID: 2892472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac electrophysiological effects of rilmenidine, a novel antihypertensive agent, in the conscious dog: comparison with clonidine.
    Boucher M; Dubar M; Chassaing C; Vivet P; Duchêne-Marullaz P
    Life Sci; 1994; 54(22):PL381-7. PubMed ID: 8177003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models.
    van Zwieten PA; Thoolen MJ; Jonkman FA; Wilffert B; de Jonge A; Timmermans PB
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):130-49. PubMed ID: 2870686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lofexidine and clonidine in moderate essential hypertension.
    Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
    Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism by E. coli endotoxin of some cardiovascular effects induced in the rat by two alpha 2-adrenoceptor agonists.
    Auclair MC; Schmitt H
    Eur J Pharmacol; 1987 Sep; 141(2):283-90. PubMed ID: 2890531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions of L-NAME and methylene blue on the hypotensive effects of clonidine and rilmenidine in the anesthetized rat.
    Soares de Moura RS; Leão MC; Castro Resende AC; Moreira CF; Sena KM; Silveira SS; Lima AF; Nunes FR; Mesquita Ferreira AG
    J Cardiovasc Pharmacol; 2000 May; 35(5):791-5. PubMed ID: 10813383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects.
    Spiegel R; DeVos JE
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):165S-168S. PubMed ID: 6994771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.